TrialBMC neurology2020

Efficacy of andrographolide in not active progressive multiple sclerosis: a prospective exploratory double-blind, parallel-group, randomized, placebo-controlled trial.

Ethel Ciampi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.